FDA Investigator Daryl A Dewoskin

Daryl A Dewoskin has inspections in 3 countries as of 12 Sep 2023. Daryl A Dewoskin has collaborated with a combinined 4770 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
12 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Aaron J Fox, Alice C Silva, Almaris N Alonso, Amber G Wardwell, Amy C Jordan, Amy N Chen, Andrew M Barlow, Angela E Glenn, Anthony C Warchut, Anthony N Onianwa, Arie C Menachem, Arlene M Badillo, Arsen Karapetyan, Azza Talaat, Barbara G Swan, Bill Tacket, Jr, Bradley D Newsad, Brandy N Lepage, Brenda P King, Brenna L Macdowell, Brittny C Cargo, Burnell M Henry, Calvin B Koerner, Camerson E Moore, Carrie A Hughes, CDR Ileana Barreto Pettit, Charles R Clavet, Cheryl A Clausen, Christie A Soto, Christopher D Leach, Christopher M Elliott, Christos G Tsingelis, Constance Desimone, Courtney N Long, Cynthia Jim, CSO, Damaris Y Hernandez, Daniel J Roberts, Daniel L Zheng, Darcy L Webber, Darin S Wiegers, David J Hafner, David P King, Deborah J Parris, Dell S Moller, Denise M Digiulio, Devaughn Edwards, Diane C Thibodeau, Dien N Nguyen, Dillard H Woody, Jr, Donald C Obenhuber, PhD, Douglas Florentino, Dr. Dominick Roselle, Edmund F Mrak, Jr, Edward H Maticka, Edward J Janik, Elise L Mcdevitt, Elizabeth B Griffin, Eric C Schmitt, Erik M Koester, Erik W Koester, Erin I Keith, Erin P Conlin, Ernest A Clausnitzer, Felix Maldonado, Garry H Stewart, Gene R Gunn, George M Ibrahim, George T Allen, Jr, Geraldine D Sanders, Gerard D Difiore, Gerardo Z Vazquez, German Rivera, Gretchen M Laws, Harshal J Desai, Helen B Ricalde, Hunt, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Liubicich, James W Whitney, Javier O Vega, Jawaid Hamid, Jay M Patria, Jean A Peeples, Jeffrey J Thibodeau, Jeffrey S Buckser, Jennifer A Robinson, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jessica L Pressley, Joanne E King, Jogy George, John A Sciacchitano, John P Mistler, Jolanna A Norton, Jonathan G Matrisciano, Jose A Torres, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Martinez, Jr, Jose Perez Soto, Joshua J Silvestri, Joyce A Kellett, Julie D Bringger, Jun Park, PhD, Justine M Corson, Karen A Briggs, Karen G Hirshfield, Karen Mcnabb Noon, Karl D Hezel, Katherine Szestypalow, Kathleen E Mcafoose, Kelly I Anderson, Kenneth H Williams, Kenneth M Gordon, Kent A Conforti, Kimberly M White, Kristina J Donohue, Kristina M Joyce, Kristy E Zuroski, Ladislav Kermet, Larry K Austin, Latorie S Jones, Laura L Staples, Laurie B Frazier, LCDR Debra Emerson, LCDR Michael H Tollon, Lei Zhang, PhD, Leiyun Boone, PhD, Lesley K Satterwhite, Leslie A Cartmill, Liatte Kreuger, PharmD, Lisa Sg Shelton, Lori M Newman, Lourdes Andujar, LT Daveta L Bailey, LT Kimberly M Hull, LT Richard A Lyght, Luis M Burgos Medero, Lundy H Patrick, Lynne Ensor, M Patriciaurphy Murphy, Mabany Lizardi, Maria Joselopez Barragan, PhD, Marian E Ramirez, Marianela Aponte Cruz, Marie A Fadden, Mark C Lookabaugh, Mark R Mcclain, Mark Sassaman, Marvin D Jones, Mary Jeanet Mcgarry, Maryam Tabatabaie, Marybet Lopez, Matthew B Casale, Matthew C Watson, Maya M Davis, Megan A Haggerty, Meghan Murphy, Melanie G Warzala, Melanie W Pishnery, Michael P Sheehan, Michael R Klapal, Michael Serrano, Michael Shanks, MS, Michele L Forster, PhD, Michelle M Noe, Michelle M Noe Varga, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Mikayla K Deardorff, Mizanne E Lewis, Moraima J Ramos Valle, Nabil Nakhoul, Nakesha J Jackson, Nancy A Saxenian, Nancy A Saxenian Emmons, Nancy T Waites, Nealie C Newberger, Nicholas L Paulin, Nicolas Riveratorres, Nicole E Knowlton, Nicole K Trudel, Noreen Muniz, Noreen Muñiz, Paraluman S Leonin, Patricia Fhughes Troost, Paul L Figarole, Jr, Paula A Trost, Paula M Laplant, Philip F Istafanos, DMV, MS, Philip H Lafleur, Philip Kreiter, Qin Xu, Qing Joanna Zhou, PhD, Ramesh Sood, Ramon E Martinez, Ravindra K Kaallwal, Rebecca B Welch, Reyes Candau Chacon, PhD, Richard H Penta, Richard Ledwidge (nmi), PhD, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert Mo Brien, Rodney W Lenger, Ronald T Weber, Rory K Geyer, Rosario D'costa, Rose Xu, Russell J Glapion, Saleem A Akhtar, Salvatore N Randazzo, Samantha J Bradley, Samantha J Pinizzotto, D V M, Samuel T Walker, Sarah E Mcmullen, Saundrea A Munroe, Sean R Bryd, Sean R Marcsisin, Shari H Shambaugh, Shirley J Berryman, Stacey S Degarmo, State Agency, Stephanie D Crockett, Stephen C Smith, Stephen R Souza, Steven A Brettler, Steven D Kehoe, Steven Fong, MS, PhD, Sue Lee Chan, Susanne M Richardson, MSc RAC ELS, Suzanne M Healy, Taichun Qin, PhD, Tajah L Blackburn, Tamara M Casselman, Tamara S Rosbury, Tamil Arasu, PhD, Tanya R Syffrard, Theresa Kirkham (NMI), Thomas Cote, Thomas W Nerney, Timothy M Glod, Tracy L Reed, Victoria M Daddeo, Virgilio F Pacio, CSO, Virginia L Meeks, Wayne E Seifert, Wendy G Tan, PhD, Wendy M Stone, William Hallett, PhD, Yetao Jin, PhD, Yumi J Hiramine, Zada L Giles, Zakaria Wahba, Zhihao Qiu (Peter), PhD, Ziyang Su, PhD

Daryl A Dewoskin's Documents

Publish Date Document Type Title
February, 2003 FDA 483 New England Compounding Center - Form 483, 2003-02-10
July, 2000 EIR AstraZeneca LP - EIR, 2000-07-31
October, 2001 FDA 483 Tower Laboratories Ltd - Form 483, 2001-10-02
September, 2007 EIR JMI Daniels Pharmaceuticals, Inc - EIR, 2007-09-21
March, 2000 EIR KIK Custom Products Inc. - EIR, 2000-03-23
July, 2003 FDA 483 AstraZeneca LP - Form 483, 2003-08-01
December, 2002 FDA 483 Michael Steller, M.D. - Form 483, 2002-12-05
March, 2008 FDA 483 VistaPharm, LLC - Form 483, 2008-03-31
November, 2001 FDA 483 Cardinal Enterprises Inc. - Form 483, 2001-11-08
November, 2010 FDA 483 Wittman Pharma, Inc. - Form 483, 2010-11-24
February, 2003 EIR New England Compounding Pharmacy, Inc. - EIR, 2003-02-10
June, 2003 FDA 483 Cardinal Enterprises Inc. - Form 483, 2003-06-02
May, 2008 FDA 483 Coast Quality Pharmacy, LLC dba Anazao Health - Form 483, 2008-05-21
July, 2000 FDA 483 AstraZeneca LP - Form 483, 2000-07-31
November, 2007 FDA 483 International Laboratories, LLC - Form 483, 2007-11-15
June, 2002 EIR John A. Stoukides, M.D. - EIR, 2002-06-04
November, 2000 EIR KIK Custom Products Inc. - EIR, 2000-11-06
September, 2007 FDA 483 JMI Daniels Pharmaceuticals, Inc - Form 483, 2007-09-21
November, 2007 EIR International Laboratories, LLC - EIR, 2007-11-15
February, 2003 FDA 483 Response New England Compounding Pharmacy, Inc. - Form 483R, 2003-02-26
December, 2008 FDA 483 Ion Labs Inc - Form 483, 2008-12-31
November, 2010 FDA 483 TG United Labs, Inc. - Form 483, 2010-11-24
September, 2002 EIR AbbVie Bioresearch Center - EIR, 2002-09-13
February, 2003 FDA 483 New England Compounding Pharmacy, Inc. - Form 483, 2003-02-10
December, 2008 EIR Ion Labs Inc - EIR, 2008-12-31
August, 2005 FDA 483 AstraZeneca LP - Form 483, 2005-08-16
August, 2010 FDA 483 Abba Pharma, Inc - Form 483, 2010-08-30
March, 2000 FDA 483 KIK Custom Products Inc. - Form 483, 2000-03-23
October, 2010 FDA 483 Bausch & Lomb Incorporated - Form 483, 2010-10-25
March, 2004 FDA 483 Alcor Scientific, Inc. - Form 483, 2004-03-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more